17476007

Source:http://linkedlifedata.com/resource/pubmed/id/17476007

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0029458, umls-concept:C0087111, umls-concept:C0257685
pubmed:issue	18
pubmed:dateCreated	2007-5-3
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00049829
pubmed:abstractText	A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in postmenopausal women with osteoporosis. We assessed the effects of annual infusions of zoledronic acid on fracture risk during a 3-year period.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17476015, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17476024, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17699824, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17703527, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17703528, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17703529, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17703530, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17764122, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-17909236, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-18312167, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-18314545, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-18314546, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-18460260, http://linkedlifedata.com/resource/pubmed/commentcorrection/17476007-20463438
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents, http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1533-4406
pubmed:author	pubmed-author:BlackDennis MDM, pubmed-author:BoonenStevenS, pubmed-author:CaminisJohnJ, pubmed-author:CauleyJane AJA, pubmed-author:CosmanFeliciaF, pubmed-author:CummingsSteven RSR, pubmed-author:DelmasPierre DPD, pubmed-author:EastellRichardR, pubmed-author:EriksenErik FinkEF, pubmed-author:HORIZON Pivotal Fracture Trial, pubmed-author:HuHuilinH, pubmed-author:HueTrisha FTF, pubmed-author:KrasnowJoelJ, pubmed-author:LakatosPéterP, pubmed-author:LeungPing ChungPC, pubmed-author:ManZulemaZ, pubmed-author:MautalenCarlosC, pubmed-author:MesenbrinkPeterP, pubmed-author:ReidIan RIR, pubmed-author:Rosario-JansenTheresaT, pubmed-author:SellmeyerDeborahD, pubmed-author:TongKarenK
pubmed:copyrightInfo	Copyright 2007 Massachusetts Medical Society.
pubmed:issnType	Electronic
pubmed:day	3
pubmed:volume	356
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1809-22
pubmed:dateRevised	2010-5-13
pubmed:meshHeading	pubmed-meshheading:17476007-Aged, pubmed-meshheading:17476007-Aged, 80 and over, pubmed-meshheading:17476007-Atrial Fibrillation, pubmed-meshheading:17476007-Biological Markers, pubmed-meshheading:17476007-Bone Density, pubmed-meshheading:17476007-Bone Density Conservation Agents, pubmed-meshheading:17476007-Diphosphonates, pubmed-meshheading:17476007-Double-Blind Method, pubmed-meshheading:17476007-Drug Administration Schedule, pubmed-meshheading:17476007-Female, pubmed-meshheading:17476007-Fractures, Bone, pubmed-meshheading:17476007-Hip Fractures, pubmed-meshheading:17476007-Humans, pubmed-meshheading:17476007-Imidazoles, pubmed-meshheading:17476007-Incidence, pubmed-meshheading:17476007-Infusions, Intravenous, pubmed-meshheading:17476007-Osteoporosis, Postmenopausal, pubmed-meshheading:17476007-Risk, pubmed-meshheading:17476007-Spinal Fractures
pubmed:year	2007
pubmed:articleTitle	Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
pubmed:affiliation	University of California, San Francisco, San Francisco, CA 94107, USA. dblack@psg.ucsf.edu
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural